48.9
Niagen Bioscience, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
46.6
FY23:
49.5
FY24:
64.1
FY25:
96.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
8.94
FY22:
7.49
FY23:
5.43
FY24:
4.18
FY25:
9.60
Total assets
Change from FY21 to FY25
millions USD
FY21:
57.8
FY22:
54.1
FY23:
55.0
FY24:
68.3
FY25:
106
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
17.6
FY22:
17.9
FY23:
20.6
FY24:
17.9
FY25:
19.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
8.50
FY22:
7.52
FY23:
5.89
FY24:
4.24
FY25:
9.95
(positive)
Change from FY21 to FY25
millions USD
FY21:
31.7
FY22:
28.7
FY23:
28.5
FY24:
46.1
FY25:
76.5
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
57.8
FY22:
54.1
FY23:
55.0
FY24:
68.3
FY25:
106
All amounts in millions USD